Obesity-news.com THE LATEST IN OBESITY RESEARCH AND WEIGHTLOSS DRUG DEVELOPMENT     Join our list More information      Meridia (sibutramine) links COMPANY INFORMATION Click on picture for close-up of all 3 strengths. Meridia withdrawn Meridia was withrdrawn from the US market in 2010 due to its increased risk of heart attack and stroke compared to its very modest effect on weight loss. This page is here for archival purposes. Obesity-news resources Barbara's Meridia FAQ Meridia survey results. January/February 1999. FDA information Approval and labeling information Endocrinologic and Metabolic Drugs Advisory Committee: Meridia documents Home|Subscribe|Archives|Drug info|Contact|Media & Links|Site index|FAQs|Doctors/meetings|Admin Obesity-news is a publication of Hirsch Communications. An on-line subscription is $104.00 per month, payable in advance by American Express, VISA or Mastercard. Subscribing is simple using our secure on-line subscription form. A yearly subscription is also available for $1040 per year through EBSCO or Swets Blackwell subscription services. Please contact them for more information. Obesity-news also accepts fax orders at 703/960-7462. Copyright 1997-2013, all rights reserved. IMPORTANT: All information in this publication is believed to be accurate and true. Publisher is not liable for omissions or inaccuracies. Information in this newsletter is for educational purposes only and should not be construed as medical advice, or be used in lieu of consultation with a health care provider.